Multi-Omic Regulation of the PAM50 Gene Signature in Breast Cancer Molecular Subtypes
Breast cancer is a disease that exhibits heterogeneity that goes from the genomic to the clinical levels. This heterogeneity is thought to be captured (at least partially) by the so-called breast cancer molecular subtypes. These molecular subtypes were initially defined based on the unsupervised clu...
Main Authors: | Soledad Ochoa, Guillermo de Anda-Jáuregui, Enrique Hernández-Lemus |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00845/full |
Similar Items
-
Computational Oncology in the Multi-Omics Era: State of the Art
by: Guillermo de Anda-Jáuregui, et al.
Published: (2020-04-01) -
Functional impact of multi-omic interactions in breast cancer subtypes
by: Soledad Ochoa, et al.
Published: (2023-01-01) -
Few-shot genes selection: subset of PAM50 genes for breast cancer subtypes classification
by: Leandro Y. S. Okimoto, et al.
Published: (2024-03-01) -
Multi-Omics Analysis Detects Novel Prognostic Subgroups of Breast Cancer
by: Quang-Huy Nguyen, et al.
Published: (2020-10-01) -
The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience
by: Magdolna Dank, et al.
Published: (2023-08-01)